E
Ultragenyx Pharmaceutical Inc. RARE
$39.34 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue 18.20% -5.12%
Total Other Revenue -- --
Total Revenue 18.20% -5.12%
Cost of Revenue 3,300.21% -88.50%
Gross Profit -564.14% 431.33%
SG&A Expenses 2.67% -0.31%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 5.77% 3.07%
Operating Income 7.36% -13.43%
Income Before Tax -0.14% -1.89%
Income Tax Expenses -106.27% -64.69%
Earnings from Continuing Operations 0.10% -1.46%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 0.10% -1.46%
EBIT 7.36% -13.43%
EBITDA 8.14% -14.63%
EPS Basic 0.29% 8.01%
Normalized Basic EPS 1.71% 4.23%
EPS Diluted 0.29% 8.01%
Normalized Diluted EPS 1.71% 4.23%
Average Basic Shares Outstanding 0.20% 10.30%
Average Diluted Shares Outstanding 0.20% 10.30%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings